{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:48:42Z","timestamp":1789523322921,"version":"build-2803163510"},"reference-count":75,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1001\/jamaneurol.2018.0046","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T12:31:15Z","timestamp":1520857875000},"page":"881","source":"Crossref","is-referenced-by-count":27,"title":["The Changing Landscape of Pediatric Migraine Therapy"],"prefix":"10.1001","volume":"75","author":[{"given":"Carlyn","family":"Patterson-Gentile","sequence":"first","affiliation":[{"name":"Division of Neurology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"Szperka","sequence":"additional","affiliation":[{"name":"Division of Neurology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Department of Neurology, University of Pennsylvania, Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9995","key":"nrv180001r1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.","volume":"386","author":"Global Burden of Disease Study 2013 Collaborators","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"nrv180001r2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11916-013-0341-z","article-title":"Epidemiology of migraine and headache in children and adolescents.","volume":"17","author":"W\u00f6ber-Bing\u00f6l","year":"2013","journal-title":"Curr Pain Headache Rep"},{"issue":"5","key":"nrv180001r3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1526-4610.2011.01885.x","article-title":"Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS).","volume":"51","author":"Lipton","year":"2011","journal-title":"Headache"},{"issue":"3","key":"nrv180001r4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/jamapediatrics.2013.508","article-title":"Pharmacologic treatment of pediatric headaches: a meta-analysis.","volume":"167","author":"El-Chammas","year":"2013","journal-title":"JAMA Pediatr"},{"issue":"7","key":"nrv180001r5","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.0000000000001256","article-title":"Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine.","volume":"84","author":"Lipton","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"nrv180001r6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa1610384","article-title":"Trial of amitriptyline, topiramate, and placebo for pediatric migraine.","volume":"376","author":"Powers","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"nrv180001r7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.1526-4610.2002.02180.x","article-title":"Children\u2019s ibuprofen suspension for the acute treatment of pediatric migraine.","volume":"42","author":"Lewis","year":"2002","journal-title":"Headache"},{"issue":"1","key":"nrv180001r8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1212\/WNL.48.1.103","article-title":"Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study.","volume":"48","author":"H\u00e4m\u00e4l\u00e4inen","year":"1997","journal-title":"Neurology"},{"issue":"7","key":"nrv180001r9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/archneur.59.7.1084","article-title":"Mechanisms of action of the 5-HT1B\/1D receptor agonists.","volume":"59","author":"Tepper","year":"2002","journal-title":"Arch Neurol"},{"issue":"7","key":"nrv180001r10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1212\/01.wnl.0000238179.79888.44","article-title":"A randomized trial of rizatriptan in migraine attacks in children.","volume":"67","author":"Ahonen","year":"2006","journal-title":"Neurology"},{"issue":"10","key":"nrv180001r11","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1177\/0333102412451358","article-title":"Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design.","volume":"32","author":"Ho","year":"2012","journal-title":"Cephalalgia"},{"issue":"9","key":"nrv180001r12","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1526-4610.2008.01138.x","article-title":"Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial.","volume":"48","author":"Linder","year":"2008","journal-title":"Headache"},{"issue":"2","key":"nrv180001r13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1542\/peds.2007-0085","article-title":"Efficacy of zolmitriptan nasal spray in adolescent migraine.","volume":"120","author":"Lewis","year":"2007","journal-title":"Pediatrics"},{"issue":"6","key":"nrv180001r14","doi-asserted-by":"crossref","first-page":"e1411","DOI":"10.1542\/peds.2011-2455","article-title":"Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine.","volume":"129","author":"Derosier","year":"2012","journal-title":"Pediatrics"},{"issue":"10","key":"nrv180001r15","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1177\/0091270004268046","article-title":"Pharmacokinetics of frovatriptan in adolescent migraineurs.","volume":"44","author":"Elkind","year":"2004","journal-title":"J Clin Pharmacol"},{"issue":"22","key":"nrv180001r16","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1212\/01.wnl.0000335946.53860.1d","article-title":"Excessive acute migraine medication use and migraine progression.","volume":"71","author":"Bigal","year":"2008","journal-title":"Neurology"},{"issue":"7","key":"nrv180001r17","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s11916-014-0428-1","article-title":"Medication overuse in children and adolescents.","volume":"18","author":"Gelfand","year":"2014","journal-title":"Curr Pain Headache Rep"},{"issue":"7","key":"nrv180001r18","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1212\/WNL.59.7.1011","article-title":"Features of medication overuse headache following overuse of different acute headache drugs.","volume":"59","author":"Limmroth","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"nrv180001r19","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1542\/peds.2009-2337","article-title":"Treatment of children with migraine in emergency departments: national practice variation study.","volume":"126","author":"Richer","year":"2010","journal-title":"Pediatrics"},{"issue":"9","key":"nrv180001r20","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/head.12443","article-title":"Randomized controlled trial of treatment expectation and intravenous fluid in pediatric migraine.","volume":"54","author":"Richer","year":"2014","journal-title":"Headache"},{"issue":"3","key":"nrv180001r21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1212\/WNL.49.3.650","article-title":"Dopamine and migraine.","volume":"49","author":"Peroutka","year":"1997","journal-title":"Neurology"},{"issue":"2","key":"nrv180001r22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0196-0644(03)00716-9","article-title":"Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac.","volume":"43","author":"Brousseau","year":"2004","journal-title":"Ann Emerg Med"},{"issue":"4","key":"nrv180001r23","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1542\/peds.107.4.e62","article-title":"Tolerability and effectiveness of prochlorperazine for intractable migraine in children.","volume":"107","author":"Kabbouche","year":"2001","journal-title":"Pediatrics"},{"issue":"2","key":"nrv180001r24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jemermed.2008.08.012","article-title":"Clinical outcomes of children treated with intravenous prochlorperazine for migraine in a pediatric emergency department.","volume":"39","author":"Trottier","year":"2010","journal-title":"J Emerg Med"},{"issue":"2","key":"nrv180001r25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1542\/peds.2014-2432","article-title":"A comparison of acute treatment regimens for migraine in the emergency department.","volume":"135","author":"Bachur","year":"2015","journal-title":"Pediatrics"},{"issue":"3","key":"nrv180001r27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ajem.2010.12.020","article-title":"Prochlorperazine in children with migraine: a look at its effectiveness and rate of akathisia.","volume":"30","author":"Trottier","year":"2012","journal-title":"Am J Emerg Med"},{"issue":"4","key":"nrv180001r28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.annemergmed.2004.07.430","article-title":"Parenteral dihydroergotamine for acute migraine headache: a systematic review of the literature.","volume":"45","author":"Colman","year":"2005","journal-title":"Ann Emerg Med"},{"issue":"1","key":"nrv180001r29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1526-4610.2008.01293.x","article-title":"Inpatient treatment of status migraine with dihydroergotamine in children and adolescents.","volume":"49","author":"Kabbouche","year":"2009","journal-title":"Headache"},{"issue":"10","key":"nrv180001r30","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1526-4610.1994.hed3410578.x","article-title":"Treatment of childhood headache with dihydroergotamine mesylate.","volume":"34","author":"Linder","year":"1994","journal-title":"Headache"},{"issue":"3","key":"nrv180001r31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1212\/WNL.0000000000004108","article-title":"Increased rate of venous thrombosis may be associated with inpatient dihydroergotamine treatment.","volume":"89","author":"Tso","year":"2017","journal-title":"Neurology"},{"issue":"7","key":"nrv180001r32","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1526-4610.2005.05158.x","article-title":"Efficacy and tolerability of intravenous valproic acid in acute adolescent migraine.","volume":"45","author":"Reiter","year":"2005","journal-title":"Headache"},{"issue":"4","key":"nrv180001r33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jemermed.2015.02.024","article-title":"Intravenous sodium valproate for acute pediatric headache.","volume":"49","author":"Sheridan","year":"2015","journal-title":"J Emerg Med"},{"issue":"10","key":"nrv180001r34","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/head.12654","article-title":"Factors influencing migraine recurrence after infusion and inpatient migraine treatment in children and adolescents.","volume":"55","author":"Cobb-Pitstick","year":"2015","journal-title":"Headache"},{"issue":"2","key":"nrv180001r35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jemermed.2013.08.049","article-title":"Intravenous magnesium as acute treatment for headaches: a pediatric case series.","volume":"46","author":"Gertsch","year":"2014","journal-title":"J Emerg Med"},{"issue":"2","key":"nrv180001r36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pediatrneurol.2013.09.008","article-title":"Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders.","volume":"50","author":"Gelfand","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"5","key":"nrv180001r37","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/head.12334","article-title":"Pediatric post-traumatic headaches and peripheral nerve blocks of the scalp: a case series and patient satisfaction survey.","volume":"54","author":"Dubrovsky","year":"2014","journal-title":"Headache"},{"issue":"9","key":"nrv180001r38","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1177\/0883073814553973","article-title":"Occipital nerve blocks for pediatric posttraumatic headache: a case series.","volume":"30","author":"Seeger","year":"2015","journal-title":"J Child Neurol"},{"issue":"10","key":"nrv180001r40","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/head.12939","article-title":"Patterns of Use of peripheral nerve blocks and trigger point injections for pediatric headache: results of a survey of the American Headache Society Pediatric and Adolescent Section.","volume":"56","author":"Szperka","year":"2016","journal-title":"Headache"},{"issue":"8","key":"nrv180001r41","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jamaneurol.2017.1011","article-title":"Pediatric migraine prevention\u2014first, do no harm.","volume":"74","author":"Gelfand","year":"2017","journal-title":"JAMA Neurol"},{"issue":"10","key":"nrv180001r42","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1526-4610.2005.00262.x","article-title":"Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.","volume":"45","author":"Winner","year":"2005","journal-title":"Headache"},{"issue":"3","key":"nrv180001r43","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.2008-0642","article-title":"Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.","volume":"123","author":"Lewis","year":"2009","journal-title":"Pediatrics"},{"issue":"10","key":"nrv180001r44","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1526-4610.2006.00610.x","article-title":"Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.","volume":"46","author":"Winner","year":"2006","journal-title":"Headache"},{"issue":"8","key":"nrv180001r45","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.1526-4610.2000.040008672.x","article-title":"The efficacy of divalproex sodium in the prophylactic treatment of children with migraine.","volume":"40","author":"Caruso","year":"2000","journal-title":"Headache"},{"issue":"1","key":"nrv180001r46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1526-4610.2008.01279.x","article-title":"Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study.","volume":"49","author":"Apostol","year":"2009","journal-title":"Headache"},{"issue":"8","key":"nrv180001r47","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1046\/j.1526-4610.2002.02186.x","article-title":"Sodium valproate prophylaxis in childhood migraine.","volume":"42","author":"Serdaroglu","year":"2002","journal-title":"Headache"},{"issue":"12","key":"nrv180001r48","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1177\/0883073808318547","article-title":"Comparison of the effectiveness of topiramate and sodium valproate in pediatric migraine.","volume":"23","author":"Unalp","year":"2008","journal-title":"J Child Neurol"},{"issue":"7","key":"nrv180001r49","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1526-4610.2000.00085.x","article-title":"Effectiveness of amitriptyline in the prophylactic management of childhood headaches.","volume":"40","author":"Hershey","year":"2000","journal-title":"Headache"},{"issue":"1","key":"nrv180001r50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1468-2982.1988.0801001.x","article-title":"Flunarizine in prophylaxis of childhood migraine: a double-blind, placebo-controlled, crossover study.","volume":"8","author":"Sorge","year":"1988","journal-title":"Cephalalgia"},{"issue":"1","key":"nrv180001r51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejpn.2012.10.001","article-title":"Comparison of flunarizine and topiramate for the prophylaxis of pediatric migraines.","volume":"17","author":"Kim","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"issue":"6","key":"nrv180001r52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pediatrneurol.2012.03.017","article-title":"Nonpharmacologic treatment of migraine with low-dose propranolol or amitriptyline.","volume":"46","author":"Eidlitz-Markus","year":"2012","journal-title":"Pediatr Neurol"},{"issue":"4","key":"nrv180001r53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/11316270-000000000-00000","article-title":"A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.","volume":"12","author":"Bidabadi","year":"2010","journal-title":"Paediatr Drugs"},{"issue":"11","key":"nrv180001r54","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s12098-013-0976-0","article-title":"Topiramate and propranolol for prophylaxis of migraine.","volume":"80","author":"Fallah","year":"2013","journal-title":"Indian J Pediatr"},{"key":"nrv180001r55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1526-4610.2012.02233.x","article-title":"CoEnzyme Q10 and riboflavin: the mitochondrial connection.","volume":"52","author":"Markley","year":"2012","journal-title":"Headache"},{"issue":"5","key":"nrv180001r56","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10194-009-0142-2","article-title":"Riboflavin prophylaxis in pediatric and adolescent migraine.","volume":"10","author":"Cond\u00f2","year":"2009","journal-title":"J Headache Pain"},{"issue":"11","key":"nrv180001r57","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1177\/0883073808318053","article-title":"High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial.","volume":"23","author":"MacLennan","year":"2008","journal-title":"J Child Neurol"},{"issue":"12","key":"nrv180001r58","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1177\/0333102410365106","article-title":"Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial.","volume":"30","author":"Bruijn","year":"2010","journal-title":"Cephalalgia"},{"issue":"8","key":"nrv180001r59","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/0333102413519512","article-title":"Nutraceuticals in the prophylaxis of pediatric migraine: Evidence-based review and recommendations.","volume":"34","author":"Orr","year":"2014","journal-title":"Cephalalgia"},{"issue":"3","key":"nrv180001r60","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1526-4610.2011.01847.x","article-title":"Nutraceuticals and headache: the biological basis.","volume":"51","author":"Taylor","year":"2011","journal-title":"Headache"},{"issue":"6","key":"nrv180001r61","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1526-4610.1997.3706383.x","article-title":"Visual evoked potentials and serum magnesium levels in juvenile migraine patients.","volume":"37","author":"Aloisi","year":"1997","journal-title":"Headache"},{"issue":"4","key":"nrv180001r62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1468-2982.1996.1604257.x","article-title":"Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study.","volume":"16","author":"Peikert","year":"1996","journal-title":"Cephalalgia"},{"issue":"5","key":"nrv180001r63","first-page":"481","article-title":"Magnesium in the prophylaxis of primary headache and other periodic disorders in children [in Italian].","volume":"15","author":"Castelli","year":"1993","journal-title":"Pediatr Med Chir"},{"issue":"6","key":"nrv180001r64","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1526-4610.2003.03102.x","article-title":"Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial.","volume":"43","author":"Wang","year":"2003","journal-title":"Headache"},{"issue":"4","key":"nrv180001r65","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1212\/01.WNL.0000151975.03598.ED","article-title":"Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial.","volume":"64","author":"S\u00e1ndor","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"nrv180001r66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1526-4610.2007.00652.x","article-title":"Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine.","volume":"47","author":"Hershey","year":"2007","journal-title":"Headache"},{"issue":"8","key":"nrv180001r67","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/0333102411406755","article-title":"A randomized, double-blinded, placebo-controlled, crossover, add-on study of coenzyme Q10 in the prevention of pediatric and adolescent migraine.","volume":"31","author":"Slater","year":"2011","journal-title":"Cephalalgia"},{"issue":"1","key":"nrv180001r68","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.spen.2016.01.010","article-title":"Complementary and integrative approaches for pediatric headache.","volume":"23","author":"Kedia","year":"2016","journal-title":"Semin Pediatr Neurol"},{"issue":"3","key":"nrv180001r69","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1526-4610.2005.05044.x","article-title":"Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract.","volume":"45","author":"Pothmann","year":"2005","journal-title":"Headache"},{"issue":"4","key":"nrv180001r70","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1517\/13543784.15.4.367","article-title":"Potential therapeutic use of melatonin in migraine and other headache disorders.","volume":"15","author":"Peres","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"nrv180001r71","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/1574886309666140605114614","article-title":"Safety and efficacy of melatonin in pediatric migraine prophylaxis.","volume":"10","author":"Fallah","year":"2015","journal-title":"Curr Drug Saf"},{"issue":"4","key":"nrv180001r72","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10072-008-0983-5","article-title":"Melatonin to prevent migraine or tension-type headache in children.","volume":"29","author":"Miano","year":"2008","journal-title":"Neurol Sci"},{"issue":"24","key":"nrv180001r73","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1001\/jama.2013.282533","article-title":"Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial.","volume":"310","author":"Powers","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"nrv180001r74","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/head.12635","article-title":"Pilot randomized controlled trial of internet-delivered cognitive-behavioral treatment for pediatric headache.","volume":"55","author":"Law","year":"2015","journal-title":"Headache"},{"key":"nrv180001r75","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1129-2377-15-12","article-title":"Headstrong intervention for pediatric migraine headache: a randomized clinical trial.","volume":"15","author":"Rapoff","year":"2014","journal-title":"J Headache Pain"},{"key":"nrv180001r26","author":"Hagler","year":"2016"},{"key":"nrv180001r39","author":"Szperka","year":"2016"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2674283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T12:34:24Z","timestamp":1531139664000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2018.0046"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":75,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2018.0046","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,1]]}}}